患者年龄是分化型甲状腺癌复发的独立危险因素,并能改善美国甲状腺协会分层系统的性能
研究纳入四家机构1603例接受甲状腺切除术和放射性碘治疗的分化型甲状腺癌患者,中位年龄49岁,无病生存期44个月,复发率8%。将年龄>55岁加入ATA分层系统可识别最高复发风险亚组。
要点
- 55岁以上分化型甲状腺癌患者复发风险显著更高(HR 1.78,95%CI 1.23-2.56)。
- 将年龄>55岁加入ATA分层系统可识别最高复发风险亚组。
核心结论
- 第八版TNM分期采用的年龄阈值55岁也能识别复发风险更高的分化型甲状腺癌患者。
- 将诊断时年龄>55岁应用于ATA风险分层系统可识别复发风险最高的患者。
研究设计与样本
- 研究期间四家机构选取接受甲状腺切除术和放射性碘治疗且随访至少一年的分化型甲状腺癌患者。
- 研究纳入1603例分化型甲状腺癌患者,中位年龄49岁,无病生存期44个月。
主要发现
- 疾病复发率为8%。
- 年龄最大的患者无病生存期最短。
- 55岁以上患者风险显著更高(HR 1.78,95%CI 1.23-2.56)。
- 高危组中55岁以上患者复发风险显著更高(HR 2.15,95%CI 2.01-4.53),而中危和低危组无显著关联。
关键数值与推荐
- Cox比例风险分析显示年龄 cutoff 55岁和ATA系统是复发的显著预测因素。
- 将诊断时年龄>55岁加入ATA系统可识别最高复发风险亚组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-category system for estimating the risk of recurrence of differentiated thyroid carcinoma (DTC). This system includes several perioperative features, but not age at diagnosis. However, age has traditionally been recognized as a critical factor in the survival of DTC patients, and the eighth edition of TNM stated that patients older than 55 years were at higher risk of death. In this study, we raised the question of whether age at DTC diagnosis impacts on its risk of recurrence. Specifically, the present study aimed to (i) evaluate the association between age at diagnosis and structural recurrence and (ii) investigate whether age at diagnosis could improve the performance of the ATA system. Methods: During the study period, four institutions selected DTC patients treated with both thyroidectomy and radioiodine and who had follow-up for at least one year. Patients with proven structural evidence of disease during follow-up were identified, and disease-free survival (DFS) was calculated accordingly. Results: The study involved 1603 DTC patients with a median age of 49 years and DFS of 44 months. Disease recurred in 8%. The shortest DFS was found in the oldest patients. The Kaplan-Meier curves were calculated for each decade of age, and there was a significant association with DFS (p = 0.0014). Patients older than 55 years had significantly higher risk (hazard ratio [HR] 1.78, 95% confidence interval [CI 1.23-2.56]). The Kaplan-Meier curves of DFS in high-, intermediate- and low-risk groups showed a significant association only in the high-risk group (p = 0.0058). Patients older than 55 years had significantly higher risk of relapse over time only in the high-risk group (HR 2.15 [CI 2.01-4.53]). Cox's proportional analysis showed that the age cutoff of 55 years and the ATA system were significant predictors of relapse. Adding age at diagnosis above 55 years to the ATA system identified a subgroup of patients at highest risk for relapse. Conclusions: The age threshold adopted in the eighth edition of TNM staging system for DTC patients' prognosis also identifies cases at higher risk of relapse. Applying age at diagnosis, with a cutoff of 55 years, to the ATA risk stratification system identifies cases at highest risk of relapse.
引用
- Trimboli P, Piccardo A, Signore A, et al. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System. Thyroid. 2020. PMID: 31973653. doi:10.1089/thy.2019.0688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。